NO911158L - Hydantoinderivater. - Google Patents
Hydantoinderivater.Info
- Publication number
- NO911158L NO911158L NO91911158A NO911158A NO911158L NO 911158 L NO911158 L NO 911158L NO 91911158 A NO91911158 A NO 91911158A NO 911158 A NO911158 A NO 911158A NO 911158 L NO911158 L NO 911158L
- Authority
- NO
- Norway
- Prior art keywords
- hydantoin derivatives
- alkyl
- formula
- nrmo
- cnr
- Prior art date
Links
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 title abstract 2
- 150000001469 hydantoins Chemical class 0.000 title abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 abstract 1
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4009506A DE4009506A1 (de) | 1990-03-24 | 1990-03-24 | Hydantoinderivate |
Publications (2)
Publication Number | Publication Date |
---|---|
NO911158D0 NO911158D0 (no) | 1991-03-22 |
NO911158L true NO911158L (no) | 1991-09-25 |
Family
ID=6402986
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91911158A NO911158L (no) | 1990-03-24 | 1991-03-22 | Hydantoinderivater. |
Country Status (18)
Country | Link |
---|---|
US (1) | US5686421A (ko) |
EP (1) | EP0449079B1 (ko) |
JP (1) | JP3003252B2 (ko) |
KR (1) | KR100197329B1 (ko) |
AU (1) | AU634039B2 (ko) |
BR (1) | BR9101121A (ko) |
CA (1) | CA2038848C (ko) |
DE (2) | DE4009506A1 (ko) |
DK (1) | DK0449079T3 (ko) |
ES (1) | ES2082026T3 (ko) |
GR (1) | GR3018826T3 (ko) |
IE (1) | IE910958A1 (ko) |
IL (1) | IL97657A (ko) |
NO (1) | NO911158L (ko) |
NZ (1) | NZ237548A (ko) |
PT (1) | PT97114B (ko) |
TW (1) | TW213469B (ko) |
ZA (1) | ZA912178B (ko) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ239846A (en) * | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
IL99537A (en) * | 1990-09-27 | 1995-11-27 | Merck & Co Inc | Fibrinogen receptor antagonists and pharmaceutical preparations containing them |
US5264420A (en) * | 1990-09-27 | 1993-11-23 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
DE4126277A1 (de) * | 1991-08-08 | 1993-02-11 | Cassella Ag | Hydantoinderivate |
DE4207254A1 (de) * | 1992-03-07 | 1993-09-09 | Cassella Ag | 4-oxo-2-thioxoimidazolidin-derivate |
DE4213634A1 (de) * | 1992-04-24 | 1993-10-28 | Cassella Ag | 2,4-Dioxo-imidazolidin-Derivate |
DE4228717A1 (de) * | 1992-08-28 | 1994-03-03 | Cassella Ag | Imidazolidin-Derivate |
DE4301747A1 (de) * | 1993-01-23 | 1994-07-28 | Cassella Ag | Substituierte Aminoverbindungen, ihre Herstellung und ihre Verwendung |
DE4308034A1 (de) * | 1993-03-13 | 1994-09-15 | Cassella Ag | Neue Heterocyclen, ihre Herstellung und ihre Verwendung |
DE4309867A1 (de) * | 1993-03-26 | 1994-09-29 | Cassella Ag | Neue Harnstoffderivate, ihre Herstellung und Verwendung |
DE4427979A1 (de) * | 1993-11-15 | 1996-02-15 | Cassella Ag | Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung |
DE59706273D1 (de) | 1996-03-20 | 2002-03-21 | Hoechst Ag | Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
KR19990012061A (ko) * | 1997-07-26 | 1999-02-25 | 성재갑 | 파네실 전이효소 저해제로 유용한 하이덴토인 유도체 |
US6384061B1 (en) * | 1997-07-26 | 2002-05-07 | Lg Chemical Ltd. | Hydantoin compounds and methods related thereto |
DE19741235A1 (de) | 1997-09-18 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19741873A1 (de) * | 1997-09-23 | 1999-03-25 | Hoechst Marion Roussel De Gmbh | Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19751251A1 (de) * | 1997-11-19 | 1999-05-20 | Hoechst Marion Roussel De Gmbh | Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate |
DE19821483A1 (de) | 1998-05-14 | 1999-11-18 | Hoechst Marion Roussel De Gmbh | Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE19922462A1 (de) | 1999-05-17 | 2000-11-23 | Aventis Pharma Gmbh | Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE10111877A1 (de) | 2001-03-10 | 2002-09-12 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate |
DE10137595A1 (de) * | 2001-08-01 | 2003-02-13 | Aventis Pharma Gmbh | Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4578079A (en) * | 1982-08-04 | 1986-03-25 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4614517A (en) * | 1982-08-04 | 1986-09-30 | La Jolla Cancer Research Foundation | Tetrapeptide |
US4683291A (en) * | 1985-10-28 | 1987-07-28 | Scripps Clinic And Research Foundation | Platelet binding inhibitors |
ZW6189A1 (en) * | 1988-05-09 | 1990-05-09 | Smithkline Beckman Corp | Anti-aggregatory peptides |
DE4126277A1 (de) * | 1991-08-08 | 1993-02-11 | Cassella Ag | Hydantoinderivate |
-
1990
- 1990-03-24 DE DE4009506A patent/DE4009506A1/de not_active Withdrawn
-
1991
- 1991-03-19 EP EP91104195A patent/EP0449079B1/de not_active Expired - Lifetime
- 1991-03-19 DE DE59106881T patent/DE59106881D1/de not_active Expired - Lifetime
- 1991-03-19 ES ES91104195T patent/ES2082026T3/es not_active Expired - Lifetime
- 1991-03-19 DK DK91104195.2T patent/DK0449079T3/da active
- 1991-03-22 IE IE095891A patent/IE910958A1/en not_active IP Right Cessation
- 1991-03-22 ZA ZA912178A patent/ZA912178B/xx unknown
- 1991-03-22 IL IL9765791A patent/IL97657A/en not_active IP Right Cessation
- 1991-03-22 CA CA002038848A patent/CA2038848C/en not_active Expired - Lifetime
- 1991-03-22 KR KR1019910004522A patent/KR100197329B1/ko not_active IP Right Cessation
- 1991-03-22 BR BR919101121A patent/BR9101121A/pt unknown
- 1991-03-22 JP JP3081158A patent/JP3003252B2/ja not_active Expired - Lifetime
- 1991-03-22 NO NO91911158A patent/NO911158L/no unknown
- 1991-03-22 NZ NZ237548A patent/NZ237548A/en unknown
- 1991-03-22 AU AU73653/91A patent/AU634039B2/en not_active Ceased
- 1991-03-22 PT PT97114A patent/PT97114B/pt not_active IP Right Cessation
- 1991-04-12 TW TW080102803A patent/TW213469B/zh active
-
1995
- 1995-06-06 US US08/467,526 patent/US5686421A/en not_active Expired - Lifetime
-
1996
- 1996-01-31 GR GR960400214T patent/GR3018826T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT97114B (pt) | 1998-08-31 |
IL97657A (en) | 1995-08-31 |
JP3003252B2 (ja) | 2000-01-24 |
EP0449079A2 (de) | 1991-10-02 |
ES2082026T3 (es) | 1996-03-16 |
US5686421A (en) | 1997-11-11 |
DE4009506A1 (de) | 1991-09-26 |
KR910016709A (ko) | 1991-11-05 |
TW213469B (ko) | 1993-09-21 |
IE910958A1 (en) | 1991-09-25 |
KR100197329B1 (ko) | 1999-06-15 |
CA2038848A1 (en) | 1991-09-25 |
PT97114A (pt) | 1991-11-29 |
BR9101121A (pt) | 1991-11-05 |
ZA912178B (en) | 1991-12-24 |
IL97657A0 (en) | 1992-06-21 |
JPH04217962A (ja) | 1992-08-07 |
DK0449079T3 (da) | 1996-03-11 |
CA2038848C (en) | 2002-01-22 |
AU7365391A (en) | 1991-10-03 |
EP0449079B1 (de) | 1995-11-15 |
NO911158D0 (no) | 1991-03-22 |
EP0449079A3 (en) | 1992-08-26 |
GR3018826T3 (en) | 1996-04-30 |
NZ237548A (en) | 1992-05-26 |
DE59106881D1 (de) | 1995-12-21 |
AU634039B2 (en) | 1993-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO911158L (no) | Hydantoinderivater. | |
BG95818A (en) | Herbicides | |
ES2167371T3 (es) | Derivados de 1h-3-aril-pirrolidin-2,4-diona espirociclicos substituidos. | |
NZ215008A (en) | Heterocyclic compounds and herbicidal compositions | |
ATE119774T1 (de) | Imidazopyridinderivate und ihre verwendung. | |
FI982436A (fi) | Kondensoituneet heterosykliset yhdisteet | |
GR3005072T3 (ko) | ||
ES2000185A6 (es) | Procedimiento para preparar derivados de acidos piridoncaboxilicos | |
DK594486A (da) | Heterocykliske forbindelser | |
NO953052L (no) | Nye pyrrolokarbazoler | |
ES8609204A1 (es) | Procedimiento de preparar derivados aminicos | |
ES8307792A1 (es) | Un metodo de produccion de compuesto de dihidropiridina. | |
ES8702378A1 (es) | Un derivado de triazol n-sustituido | |
DK147588A (da) | Benzoxazinderivat samt fremgangsmaade til fremstilling deraf | |
MC1919A1 (fr) | Derives de l'imidazole | |
ATE144900T1 (de) | Verwendung von xanthinderivaten gegen magengeschwüre | |
IE893533L (en) | Substituted 3-aminosydnonimines, processes for their¹preparation and their use | |
JPS6463569A (en) | Heteroaryl derivative | |
TH14567A (ko) | ||
TH14957EX (th) | สารประกอบชนิดใหม่ | |
TH14567EX (th) | สารประกอบแอโซล, การผลิตและการใช้สารเหล่านี้ | |
ES8307812A1 (es) | Un procedimiento para la preparacion de nuevos amidin derivados del acido clavulawilo. | |
TH13791EX (th) | อนุพันธ์ต่างๆของกรดบิวไทริค | |
SE7901316L (sv) | Derivat av dehydrocykliciminsyror |